Loading...
OTCM
EAPH
Market cap6kUSD
May 22, Last price  
0.00USD
1D
600.00%
1Q
600.00%
Jan 2017
-99.98%
Name

Easton Pharmaceuticals Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
300,00040,160105,789173,3440067,428000378,5891,555,566000
Net income
0k
-8,398,760-6,299,217-2,199,072-3,980,2320-346,533-360,848-599,941-872,82264,062-169,227-323,171-188,54200
CFO
0k
-1,457,375-2,692,347-701,537-1,583,2610-172,436-197,667-227,555-863,383-6,856510,680-188,54200

Profile

Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.
IPO date
Sep 29, 2000
Employees
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
0.00
-99.50%
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT